AbbVie and Eli Lilly have left the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), according to an update issued this morning by the Association of the British Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback